New analysis

Nasdaq Inc NDAQ

A toll-bridge exchange wrapped around a debt-funded software bet, priced for perfection.
12-year-old test
Nasdaq runs the stock exchange where many companies first sell shares. It also owns the Nasdaq-100 index, which giant funds pay to copy. And it sells software to banks for finding crime and following rules. The first two parts are like toll bridges — once people use them, they keep paying. The bank software is newer and cost a lot to buy. The company borrowed heavily for that purchase, which makes it riskier if business slows. Today the stock costs more than what the business is realistically worth, so a careful investor would wait for a lower price.
Composite Score
61
/ 100
Above median
Recommendation
Hold
Add only below $55
Trim above $105.
Intrinsic Value (Base)
$41 · $60 · $111
Px $87 · 53% above IV (no margin of safety)

Quantitative scorecard

/100 · weighted equally across four pillars
Profitability quality
18/25
ROIC 10y avg7.8%
ROIIC 5y3.8%
FCF / NI (5y)123.1%
Gross margin trendexpanding
Op-margin stability5.0%
Balance sheet
16/25
Net debt / EBITDA4.10x
Interest coverage
Current ratio1.00x
Goodwill / equity118.9%
Off-balanceClean
Capital allocation
15/25
Share count Δ 10y14.7%
Buyback timingMixed
Dividend payout43.2%
M&A track recordOrganic
CEO communicationDefault
Valuation
12/25
P/E vs 10y avg1.40x
EV/FCF vs 10y avg1.44x
Reverse-DCF growth15.4%
Px / Base IV1.53x
Margin of safetyAbsent
Owner Earnings (TTM)
USD
Net income (TTM)$1.28B
+ Depreciation & amortization+ derived
+ Stock-based compensation+ derived
− Maintenance capexmedian of Greenwald / D&A / capex-rev− $164.79M
− Δ Working capital− derived
= Owner Earnings$1.40B
For comparison: GAAP FCF (TTM)$1.85B

Thesis

Nasdaq Inc is three businesses stitched together: (1) a regulated equity-listings and trading franchise that throws off cash because U.S. companies must list somewhere and Nasdaq has the brand for tech IPOs; (2) a fast-growing Index business (Nasdaq-100, QQQ-linked products) that earns asset-based fees with near-zero marginal cost; and (3) a Financial Technology arm (Verafin, AxiomSL, Calypso/Adenza) selling regulatory, anti-financial-crime, and capital-markets workflow software to banks. The first two are wide-moat toll bridges; the third is a software roll-up still being digested.

The scorecard says exactly what a Buffett analyst should expect from a regulated platform with a recent megadeal: 10-yr ROIC of just 7.76% (Adenza's $10.5B price tag inflated the capital base), 5-yr ROIIC of only 3.8% (incremental capital not yet earning its keep), but FCF conversion of 1.23x (cash earnings exceed accounting earnings — classic platform economics). Net debt/EBITDA of 4.10x is the elephant in the room; share count is up 14.68% over a decade from the Adenza stock issuance.

The price/IV math is unforgiving: at $91.32 versus a base IV of $59.51, you are paying 1.53x intrinsic value. The reverse-DCF demands 15.39% growth — heroic for a company that grew the listings business in low single digits. Even at the high IV of $110.72, upside is ~21% with leverage risk; at the low IV of $41.20, downside is -55%. The asymmetry is wrong. This compounds eventually, but not from here.

Moat

Nasdaq has three distinct moats of varying quality.

1. Pricing power & intangibles (Listings franchise). A U.S. equity listing is a duopoly product (NYSE/Nasdaq), and once a company is listed the SEC, exchange-rule compliance, ticker-recognition, and index-membership lock-in create switching costs that border on prohibitive. Per [3], excess returns persist where 'significant constraints have to exist on competitors entering and imitating the successful firm' — exchange registration is exactly that legal/regulatory moat. Nasdaq raises annual listing fees almost every year with negligible churn. Brand-wise, the 'Nasdaq' name is synonymous with tech IPOs, a Coca-Cola-style intangible per [1] — built over decades, not replicable with capital. Stress test: if a competitor (CBOE, IEX, MEMX) tried to recruit listings with $10B over 5 years, they'd struggle to win 50 marquee companies because index inclusion, options-class linkage, and analyst coverage all anchor at Nasdaq/NYSE. Erosion risk: low.

2. Network effects + intangibles (Index). Nasdaq-100 and the broader index family is the second-most valuable equity index franchise after S&P 500. QQQ alone is one of the largest ETFs in the world, paying Invesco a license fee to Nasdaq. The Index value pool is tiny relative to the AUM riding on it — pure rent extraction described in [4] as 'firms with more valuable brand names... usually end up with higher returns on capital, higher margins.' Switching index providers is impossible for an asset manager: the brand is the index. Stress test: $10B/5yrs cannot create 'Nasdaq-100' awareness from scratch; this is closer to Standard & Poor's brand than to a software product. Erosion risk: low, but secondary indexes face commoditization.

3. Switching costs (Market Tech / FinTech). Verafin (anti-financial-crime), AxiomSL (regulatory reporting), and Adenza/Calypso (treasury & capital-markets workflow) are deeply embedded. Banks integrate these into core operations and regulators bless their outputs. Switching means re-papering regulatory filings — a one-decade undertaking. Per [2], 'the more sustainable the competitive advantages possessed by a firm, the greater will be the value of the options embedded in the initial investment' — recurring SaaS in regulated workflows is a textbook example. But this moat is narrower than 1-2: customer concentration is high, the products compete with FIS, SS&C, Murex, Bloomberg, and the integration roadmap from the Adenza deal is still being executed.

4. Cost advantages (Market Services). Trading platforms have economies of scale — co-located matching engines spread fixed costs across volume. But trading is increasingly commoditized; routing rules (Reg NMS) force best-execution, and dark-pool/ATS competition has compressed take rates. Cost moat exists but it's narrowing.

5. Pricing power across the bundle. The cross-sell pitch — listings clients buy IR Insight, ESG Reporting, Board Portal — is real but small. Nasdaq has not yet shown durable pricing power in software comparable to Bloomberg or MSCI.

Competitor stress test ($10B / 5 years). A well-funded raider could (a) build a better matching engine — won't help, regs control routing; (b) launch a competing index — has been tried (Russell, FTSE) without dethroning Nasdaq-100; (c) buy a regtech competitor — would compress margins industry-wide. The Listings + Index core is genuinely defensible; the FinTech segment is contestable.

Erosion risks. (i) The SEC could mandate transaction-fee caps or unbundled market-data rules, eroding the Market Services and proprietary-data revenue; (ii) Index licensing economics depend on equity ETF inflows, which are cyclical; (iii) Adenza integration could fail, marooning $10.5B of goodwill. Per [1], 'managers... who take over a valuable brand name and then dissipate its value, will reduce the values of the firm substantially' — the Adenza price was full, and dissipation risk is non-trivial.

Moat verdict: NARROW. Listings + Index would qualify as WIDE on their own, but the consolidated entity carries enough contestable software revenue and regulatory tail risk to keep the verdict at NARROW.

L
Learning Note
Moat durability — the Munger filter
The test: if a well-funded competitor had $10B and 5 years, could they meaningfully damage this business? If yes, the moat is narrower than it looks.
Used in Step 5 — Moat Assessment

Management & Capital Allocation

Adena Friedman's tenure (CEO since 2017) has been defined by one strategic conviction: pivot Nasdaq from a transaction-fee-dependent exchange operator into a 'trusted fabric of the financial system' through software acquisitions. This is a real strategy, executed with consistency. Whether it has been executed at acceptable prices is a separate question.

1. Reinvestment. Organic R&D in cloud-native exchange technology (the Markets Modernization program) is reasonable, and the migration of Nasdaq's matching engines onto AWS is genuinely industry-leading. Capex is moderate and FCF conversion of 1.23x suggests reinvestment is not bleeding the cash machine.

2. Acquisitions. The headline number — $10.5 billion for Adenza in 2023 — is the entire ballgame. Adenza (Calypso + AxiomSL) was paid for with cash + ~85.6 million Nasdaq shares to Thoma Bravo. At ~18x revenue and ~31x EBITDA, the price was not Buffett-cheap. The strategic logic (recurring software, cross-sell to banks) is sound; the price discipline is questionable. Earlier Verafin ($2.75B, 2020) and AxiomSL ($590M, 2019) deals were smaller and at higher growth rates, so the math worked better. Per [5], 'managers… focusing solely on acquisition possibilities meeting these tests, have achieved excellent results.' Friedman has been disciplined about category — recurring revenue, regulated workflow — but the Adenza price reflected a 2021-vintage software multiple, locked in just as multiples reset.

3. Debt. The Adenza deal pushed net debt/EBITDA to 4.10x — the highest in the company's modern history. Management has guided to deleverage to ~3.3x by FY2025 and below 3x by 2026, and the 2024-2025 deleveraging cadence has been on track. But 4.1x is structurally fragile; one recession-driven IPO drought + a software contract slowdown and that ratio reverses. Interest coverage is not provided in the scorecard but TTM owner earnings of $1.40B against ~$8.4B of net debt implies ~6x EBIT/interest — adequate but not comfortable.

4. Buybacks. Share count is up 14.68% over 10 years — meaningful dilution from Adenza issuance. Management has historically bought back stock, but at 1.53x IV the marginal buyback today destroys value. Per Buffett's letters, buybacks above intrinsic value are a tax on continuing shareholders. To management's credit, the 2024-2025 program has been modest (~$100-200M/yr) given the leverage focus — the right call.

5. Dividends. The dividend has been raised every year since initiation, payout ratio remains ~35% of GAAP earnings. This is fine for a platform business but not a defining feature.

Communication quality. Investor days are detailed and well-modeled. Adena Friedman is a clear communicator, the segment disclosure is granular, and management has not played accounting games with the Adenza intangible amortization (it's all visible). The non-GAAP-vs-GAAP gap is wide because of acquisition amortization, but they show both. Compared to peers (CME, ICE), disclosure is strong.

Capital allocator: B. Strategy is sound and execution is competent. The Adenza price and the dilution it required prevent an A grade. If the integration delivers the promised cross-sell synergies and leverage falls under 3x by 2026, the grade upgrades.

Industry Structure

Apply Porter's Five Forces to NDAQ's three businesses (Listings, Market Services, FinTech).

1. Threat of new entrants — LOW. Operating a national securities exchange requires SEC registration as an SRO, decades of regulatory relationships, and infrastructure that costs hundreds of millions to replicate. New entrants in the U.S. exchange space (IEX, MEMX, MIAX) have gained niche share but none has dethroned Nasdaq or NYSE in listings. In FinTech, barriers are lower — competing regtech platforms (Wolters Kluwer, BlackLine, FIS) exist — but the top-3 banking customers don't switch easily.

2. Bargaining power of suppliers — LOW. Suppliers are technology vendors (AWS, hardware) and employees. AWS is concentrated but Nasdaq is a flagship customer. Talent costs are real but not pinching margins.

3. Bargaining power of buyers — MEDIUM. Listings clients are price-takers — once committed they pay annual fees. Index licensees (ETF issuers) have BlackRock/Invesco scale and can pressure economics, but Nasdaq-100 is irreplaceable. Trading firms (HFTs, broker-dealers) are powerful buyers in Market Services and have driven take rates lower over a decade. FinTech buyers are large global banks with procurement leverage, though the embedded nature of Adenza/AxiomSL workflows softens this.

4. Threat of substitutes — MEDIUM. Substitutes for a U.S. listing are: (a) staying private (Stripe, SpaceX) — a real and growing trend that shrinks the IPO pool; (b) listing abroad (rare for U.S. companies); (c) direct listings/SPACs — cyclical. For Index, substitutes are S&P 500-based products, a very real competitor. For FinTech, substitutes are 'build in-house' or rival vendors. The most serious long-run substitute is private-market growth: if companies stay private until they're $50B+, the listings funnel narrows.

5. Rivalry among existing competitors — MEDIUM-HIGH. Listings: duopoly with NYSE, intense for marquee tech IPOs but pricing is stable. Trading: extremely fragmented with ~16 venues; this is where rivalry is fiercest and margins thinnest. FinTech: highly competitive with FIS, SS&C, Murex, Bloomberg, S&P Global all in adjacent fields. Index: oligopolistic (S&P, MSCI, FTSE, Nasdaq) with stable pricing.

Value pool location and trajectory. The high-margin pools are Index (~60% operating margins, growing), Listings (~50% margins, slow growth), and Solutions/Data (~45% margins, mid-single-digit growth). Market Services is a ~30% margin commodity. The trajectory of the value pool is favorable but mixed: software/SaaS portion is growing 8-10%, but the trading and listings core grows in low single digits, and the private-markets-staying-private trend is a slow leak.

Per [3], 'over time, there is a tendency, albeit slow, for the returns at companies to converge on industry averages.' Nasdaq's regulated franchises slow that convergence; the FinTech segment accelerates it.

Industry Verdict: Good. Not Excellent because the trading layer is commoditized and private-market substitution is real; not merely Average because the regulated listings + index core sits in a structural duopoly with pricing power.

Mandatory Inversion
Inversion: the analysis below is intentionally adversarial. It is the strongest credible bear case, written without deference to the bull thesis. Weight it equally.

Inversion (Bear Case)

I am now a short-seller. The bear case for NDAQ at $91.32 is straightforward and credible.

1. The single event that kills this. A 12-18 month IPO drought combined with a credit-cycle slowdown in bank software spend. Nasdaq's listings revenue is procyclical — the Initial Listings Fees line collapses during IPO winters (2022 and 2008 are recent examples). Simultaneously, Adenza's bank-software customers cut discretionary tech spend in a hard landing. Now leverage at 4.1x EBITDA looks closer to 5x as EBITDA falls 15%. Rating agencies downgrade. The dividend gets squeezed. Multiple compresses from 41x to 22x. Stock halves. The leverage didn't matter at the top of the cycle; it's the ONLY thing that matters at the bottom.

2. Why the moat is narrower than bulls think. The Listings franchise is suffering a structural leak: U.S. private-company tenure has doubled (median IPO age went from ~7 years to ~12 years over two decades). Companies like Stripe, SpaceX, OpenAI, Databricks generate the wealth that used to fund Nasdaq listings, and they're not coming. The Index franchise is fully concentrated in QQQ, which is itself concentrated in seven Big Tech names — a 30% drawdown in mega-cap tech crushes index licensing revenue. The FinTech moat is overstated: Adenza/Calypso compete head-to-head with Murex, FIS, and SS&C; Verafin competes with NICE Actimize. Switching is hard but pricing pressure is real. Per [3], excess returns 'will undoubtedly draw in new competitors over time' — the FinTech segment is in that drawdown phase, not the moat-widening phase.

3. Why management is worse than it appears. Adena Friedman paid 18x revenue for Adenza at the absolute peak of the software bubble (Q2 2023 after enterprise software multiples had reset, but Thoma Bravo got their 2021 carry-mark price anyway). Diluting shareholders 14.7% over a decade for an asset that earns ~7.8% ROIC at the consolidated level is value-destructive on its face. Per Buffett 1981 [5], 'we would rather buy 10% of Wonderful Business T at X per share than 100% of T at 2X per share' — Friedman did the opposite. Management's communication is polished but the buyback discipline has been absent until very recently; they bought stock above IV through 2021-2022. The 'Nasdaq financial-fabric' narrative is largely a re-framing exercise to justify a roll-up that would have been called diworsification in any earlier era.

4. What bulls are extrapolating that won't hold. Bulls extrapolate (a) double-digit FinTech segment growth — but Adenza's organic growth is mid-single-digits, and the 'cross-sell synergy' has been promised on every banking-software acquisition in history with mixed delivery; (b) Index AUM growth — but this is just QQQ's price; if Nvidia/Apple/Microsoft draw down 30%, AUM-based fees fall in lockstep; (c) margin expansion from cloud migration — but cloud bills do not actually fall, AWS just moves the cost line; (d) deleveraging — true mechanically but it's just paying back a debt-funded acquisition, not creating new value. The reverse-DCF demands 15.39% growth into perpetuity. NDAQ has never grown at 15.4% sustainably; the 10-year revenue CAGR is closer to 7%.

5. Valuation trap (multiple compression / regime change). At 41x TTM earnings against a 10-year average of 29.5x, the stock is one standard deviation above its own normal. EV/FCF of 33.1x is a software-multiple, but the consolidated FCF growth is exchange-paced. If sentiment normalizes to the 10-year average P/E and earnings stay flat, the stock falls to ~$65. If a recession arrives and earnings fall 15%, fair value at the historical multiple is $55. The IV base case of $59.51 is consistent with this: 41x is paying for a re-rating that hasn't been earned. Per [4], 'no firm should be able to earn excess returns for any length of period in a competitive product market' — at 1.53x IV, you are paying for excess returns that the consolidated business is not actually generating (ROIIC of just 3.8%).

If I am right, the stock could be worth $50-55 within 3 years — a 40-45% drawdown from $91.32, landing near the IV low of $41.20 in a worst case and the IV base of $59.51 in a base case. Catalysts: IPO drought + Adenza customer churn + leverage downgrade. Time horizon: 12-36 months.

Lollapalooza Bias Check

Several biases are active in me as I write this, and I should name them.

1. Anchoring. I am anchored to the scorecard's IV base of $59.51 and the price of $91.32. The 1.53x ratio creates a strong cognitive frame ('overpriced') that is making me weight the bear case more heavily than the bull. Anchoring is rational here — the math does not lie — but I should remember that intrinsic-value estimates have wide error bars (the scorer flagged maintenance-capex uncertainty twice). The IV high of $110.72 is plausible if Adenza synergies surprise.

2. Recency bias. Software multiples reset hard in 2022-2023, and I am pattern-matching Adenza to the 'overpaid software deal' archetype that has burned investors at Salesforce/Slack, Microsoft/Activision skeptics, and others. But Adenza is regtech with high recurring revenue — a different animal from a B2C SaaS deal. Recency makes the deal look worse than it is.

3. Authority/Social proof. Buffett owns a meaningful position in Moody's, S&P, and exchanges historically. The 'exchange = wide moat' narrative has authority backing. I should resist accepting this narrative as proof for NDAQ specifically — the consolidated entity is no longer a pure exchange, and the moat argument that applies to Moody's may not transfer to a 4.1x-levered software roll-up.

4. Confirmation bias. Once I noticed ROIIC of 3.8% (a damning number for an incremental capital story), I started seeing every other data point as confirming poor capital allocation. ROIIC is a 5-year measure that captures the Adenza dilution; the next 5-year ROIIC could be much better as the deal seasons.

5. Deprival super-reaction. None active — I don't own NDAQ, so no commitment escalation.

6. Incentive bias (other-directed). Sell-side analysts cover NDAQ heavily and the consensus is bullish (Buy-skewed) because investment banking relationships and listings business sit with the same firms. This creates an 'imitation tax' — the institutional consensus is structurally optimistic on exchange operators. I should weight third-party price targets accordingly.

7. Commitment. None — fresh look.

Net read on my own state: I am probably 5-10% too negative on the qualitative side because of recency + anchoring on the 1.53x IV ratio. But the quantitative gap is large enough that even after adjusting for my biases, the conclusion holds: this is not a margin-of-safety entry point. The discipline is to wait, not to talk myself into the bull case.

10-Year Outlook

Same fundamental business model in 2036? Substantially yes for Listings and Index; partially yes for Market Services; uncertain for FinTech. The Listings + Index franchises are regulated and infrastructural — they will exist in some form. The Market Services trading layer will continue to commoditize. The FinTech segment in 2036 may have consolidated further (Nasdaq could be the buyer or the bought).

Customer base larger? Yes for Index (global ETF AUM continues to grow at high single digits). Probably yes for FinTech (banks add regulatory complexity). Uncertain for Listings (private-company tenure trend works against it; the IPO funnel could be smaller). Probably no for Market Services (consolidating venues).

Profit per customer higher? Yes for Index (price increases plus AUM growth compound). Probably yes for FinTech (cross-sell, price increases). Flat to negative for Market Services (commoditization). Modestly higher for Listings (annual fee creep).

Moat wider? Listings + Index moat is roughly stable — neither widening nor narrowing materially. FinTech moat could widen with successful Adenza integration or narrow if competitors out-execute. Net: stable.

Single biggest threat over 10 years? Two-headed: (1) the structural 'private companies stay private' trend that erodes the listings funnel; (2) a regulatory regime change on market-data unbundling or exchange-fee caps that compresses 15-20% of revenue. A third lurking threat is AI-driven disruption of regtech — if a foundation model can do AML/KYC reasoning natively, Verafin/AxiomSL margins compress.

Confidence assessment. The 10-year shape is recognizable: still an exchange, still has indices, still sells software to banks. But the level of cash flow in 2036 has wide error bars because of (a) leverage path, (b) Adenza ROIC realization, (c) regulatory regime, (d) IPO funnel. The qualitative picture is medium-confidence; the quantitative IV range is medium-confidence (the scorer flagged maintenance-capex uncertainty).

CONFIDENCE: medium

Position guidance

- **Recommendation:** Hold (existing holders), Avoid (new money)
- **Conviction:** medium
- **Target buy price:** $55 (≈10% below IV base of $59.51, gives meaningful margin of safety on a leveraged platform)
- **Target trim price:** $105 (approaching IV high of $110.72; even bull-case is largely priced in)
- **Position sizing:** If buying near $55, 2-4% portfolio weight is reasonable for a Good-industry, Narrow-moat, B-allocator name with elevated leverage. Do not exceed 4% until net debt/EBITDA falls below 3x. At current $91.32, position size should be zero for new buyers; existing holders with low cost basis can hold but should not add.